Download PDF
Thromb Haemost 1997; 77(05): 0884-0889
DOI: 10.1055/s-0038-1656072
Coagulation
Schattauer GmbH Stuttgart

Variation in Plasma Fibrinogen over One Year: Relationships with Genetic Polymorphisms and Non-genetic Factors

Sari Väisänen
1   The Kuopio Research Institute of Exercise Medicine and Department of Physiology, University of Kuopio, Finland
,
Rainer Rauramaa
1   The Kuopio Research Institute of Exercise Medicine and Department of Physiology, University of Kuopio, Finland
,
IIkka Penttilä
2   Department of Clinical Chemistry, Kuopio University Hospital, Kuopio, Finland
,
Tuomo Rankinen
1   The Kuopio Research Institute of Exercise Medicine and Department of Physiology, University of Kuopio, Finland
,
Jacques Gagnon
3   Physical Activity Sciences Laboratory, Laval University, Ste-Foy, Québec, Canada
,
Louis Pérusse
3   Physical Activity Sciences Laboratory, Laval University, Ste-Foy, Québec, Canada
,
Monique Chagnon
3   Physical Activity Sciences Laboratory, Laval University, Ste-Foy, Québec, Canada
,
Claude Bouchard
3   Physical Activity Sciences Laboratory, Laval University, Ste-Foy, Québec, Canada
› Author Affiliations
Further Information

Publication History

Received 20 September 1996

Accepted after resubmission 06 January 1997

Publication Date:
11 July 2018 (online)

  PDF Download  Permissions and Reprints

Summary

We analyzed plasma fibrinogen level in relation to genetic polymorphisms in the a- and β-fibrinogen gene loci. Furthermore, the association of other CVD risk markers with fibrinogen was studied twice, with a time interval of one year in 50 to 60 year old men (n = 183). DNA polymorphisms were detected by PCR and digestion with TaqI (α-fibrinogen), Hind III and Bcl I (β-fibrinogen) restriction enzymes. The correlation coefficient between fibrinogen measurements was 0.48 (p <0.001). Blood leucocytes and waist-to-hip circumference ratio were the strongest correlates of fibrinogen level in both examinations, and the changes in leucocyte count and plasma fibrinogen correlated positively (r = 0.40, p <0.001). In Eastern Finnish men, the Taq I, Hind III or Bcl I restriction fragment length polymorphisms of the a- or β-fibrinogen gene loci did not associate with fibrinogen level, either cross- sectionally or longitudinally.

 

  • References

  • 1 Wilhelmsen L, Svärdsudd K, Korsan-Bengtsen K, Larsson B, Welin L, Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 1984; 311: 501-505
    CrossrefPubMedGoogle Scholar
  • 2 Meade TW, Mellows S, Brozovic M, Miller GJ, Chakrabarti RR, North WRS, Haines AP, Stirling Y, Imeson JD, Thompson SG. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet 1986; 2: 533-537
    PubMedGoogle Scholar
  • 3 Meade TW, Imeson J, Stirling Y. Effects of changes in smoking and other characteristics on clotting factors and the risk of ischaemic heart disease. Lancet 1987; 2: 986-988
    PubMedGoogle Scholar
  • 4 Ernst E. Fibrinogen as a cardiovascular risk factor – interrelationship with infections and inflammation. Eur Heart J 1993; 14 (Suppl K) 82-87
    PubMedGoogle Scholar
  • 5 Ernst E. The role of fibrinogen as a cardiovascular risk factor. Atherosclerosis 1993; 100: 01-12
    CrossrefPubMedGoogle Scholar
  • 6 Ernst E, Resch KL. The “fibrinogen hypothesis”: is elevated plasma fibrinogen a major cardiovascular risk factor?. In: Atherosclerosis X. Woodford FP, Davignon J, Sniderman A. eds. Elsevier Science B.V.; Amsterdam: 1995. pp. 785-792
    Google Scholar
  • 7 Folsom AR, Wu KK, Davis CE, Conlan MG, Sorlie PD, Szklo M. Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors. Atherosclerosis 1991; 91: 191-205
    CrossrefPubMedGoogle Scholar
  • 8 Stratton JR, Chandler WL, Schwartz RS, Cerqueira MD, Levy WC, Kahn SE, Larson VG, Cain KC, Beard JC, Abrass IB. Effects of physical conditioning on fibrinolytic variables and fibrinogen in young and old healthy adults. Circulation 1991; 83: 1692-1697
    CrossrefPubMedGoogle Scholar
  • 9 Elwood PC, Yamell JWG, Pickering J, Fehily AM, O’Brien JR. Exercise, fibrinogen, and other risk factors for ischaemic heart disease. Caerphilly Prospective Heart Disease Study. Br Heart J 1993; 69: 183-187
    CrossrefPubMedGoogle Scholar
  • 10 Rankinen T, Rauramaa R, Väisänen S, Penttilä I, Saarikoski S, Tuomilehto J, Nissinen A. Inverse relationship between physical activity and plasma fibrinogen in postmenopausal women. Atherosclerosis 1993; 102: 181-186
    CrossrefPubMedGoogle Scholar
  • 11 Hassouna HI. Laboratory evaluation of hemostatic disorders. Hematology/ Oncology Clinics of North America: Coagulation Disorders II 1993; 7: 1161-1236
    PubMedGoogle Scholar
  • 12 Henschen AH. Human fibrinogen – Structural variants and functional sites. Thromb Haemostas 1993; 70: 42-47
    PubMedGoogle Scholar
  • 13 Kant JA, Fomace Jr AJ, Saxe D, Simon MI, McBride OW, Crabtree GR. Evolution and organisation of the fibrinogen locus on chromosome 4: gene duplication accompanied by transposition and inversion. Proc Natl Acad SciUSA 1985; 82: 2344-2348
    CrossrefPubMedGoogle Scholar
  • 14 Thomas A, Lamlum H, Humphries S, Green F. Linkage disequilibrium across the fibrinogen locus as shown by five genetic polymorphisms, G/A-455 (Haelll), C/T-148 (Hindlll/Alul), T/G+1689 (Avail), and Bcll (β-fibrinogen) and TaqI (α-fibrinogen), and their detection by PCR. Human Mutation 1994; 3: 79-81
    CrossrefPubMedGoogle Scholar
  • 15 Berg K, Kierulf P. DNA polymorphisms at fibrinogen loci and plasma fibrinogen concentration. Clin Genet 1989; 36: 229-235
    PubMedGoogle Scholar
  • 16 Connor JM, Fowkes FGR, Wood J, Smith FB, Donnan PT, Lowe GDO. Genetic variation at fibrinogen loci and plasma fibrinogen levels. J Med Genet 1992; 29: 480-482
    PubMedGoogle Scholar
  • 17 Humphries SE, Cook M, Dubowitz M, Stirling Y, Meade TW. Role of genetic variation at the fibrinogen locus in determination of plasma fibrinogen concentrations. Lancet 1987; 1: 1452-1455
    PubMedGoogle Scholar
  • 18 Green F, Hamsten A, Blombäck M, Humphries S. The role of β-fibrinogen genotype in determining plasma fibrinogen levels in young survivors of myocardial infarction and healthy controls from Sweden. Thromb Haemost 1993; 70: 915-920
    Article in Thieme ConnectPubMedGoogle Scholar
  • 19 Scarabin P-Y, Bara L, Ricard S, Poirier O, Cambou JP, Arveiler D, Luc G, Evans AE, Samama MM, Cambien F. Genetic variation at the β-fibrinogen locus in relation to plasma fibrinogen concentrations and risk of myocardial infarction. The ECTIM study. Arterioscler Thromb 1993; 13: 886-891
    CrossrefPubMedGoogle Scholar
  • 20 Humphries SE, Imam AMA, Robbins TP, Cook M, Carritt B, Ingle C, Williamson R. The identification of a DNA polymorphism of the fibrinogen gene and the regional assignment of the human fibrinogen genes to 4q26-qter. Hum Genet 1984; 68: 148-153
    CrossrefPubMedGoogle Scholar
  • 21 Rauramaa R, Väisänen S, Mercuri M, Rankinen T, Penttilä I, Bond MG. Association of risk factors and body iron status to carotid atherosclerosis in middle-aged Eastern Finnish men. Eur Heart J 1994; 15: 1020-1027
    CrossrefPubMedGoogle Scholar
  • 22 Rauramaa R, Rankinen T, Tuomainen P, Väisänen S, Mercuri M. Inverse relationship between cardiorespiratory fitness and carotid atherosclerosis. Atherosclerosis 1995; 112: 213-221
    CrossrefPubMedGoogle Scholar
  • 23 Borg GAV. Psychophysiological bases of perceived exertion. Med Sci Sports Exerc 1982; 14: 377-381
    PubMedGoogle Scholar
  • 24 Rauramaa R, Tuomainen P, Väisänen S, Rankinen T. Physical activity and health-related fitness in middle-aged men. Med Sci Sports Exerc 1995; 27: 707-712
    PubMedGoogle Scholar
  • 25 WHO (World Health Organization). Energy and protein requirements. Report of a joint FAO/WHO/UNU expert consultation. Technical report series 724. World Health Organization; Geneva: 1985
    Google Scholar
  • 26 Pietinen P, Hartman AM, Haapa E, Räsänen L, Haapakoski J, Palmgren J, Albanes D, Virtamo J, Huttunen JK. Reproducibility and validity of dietary assessment instruments. I. Self-administered food use questionnaire with a portion size picture booklet. Am J Epidemiol 1988; 128: 655-666
    CrossrefPubMedGoogle Scholar
  • 27 Rastas M, Seppänen R, Knuts L-R, Karvetti R-L, Varo P. Nutrient composition of foods. Publications of the Social Insurance Institution; Helsinki, Finland: 1989
    Google Scholar
  • 28 Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. ActaHaemat 1957; 17: 237-246
    PubMedGoogle Scholar
  • 29 Penttilä IM, Voutilainen E, Laitinen P, Juutilainen P. Comparison of different analytical and precipitation methods for direct estimation of serum high-density lipoprotein cholesterol. Scand J Clin Lab Invest 1981; 41: 353-360
    CrossrefPubMedGoogle Scholar
  • 30 Pinnell AE, Northam BE. New automated dye-binding method for serum albumin determination with bromcresol purple. Clin Chem 1978; 24: 80-86
    PubMedGoogle Scholar
  • 31 The committee of enzymes of the Scandinavian society for clinical chemistry and clinical physiology. Recommended method for the determination of γ-glutamyltransferase in blood. Scand J Clin Lab Invest 1976; 36: 119-125
    CrossrefPubMedGoogle Scholar
  • 32 Sambrook J, Fritsch EF, Maniatis T. eds. Molecular cloning: A laboratory manual. Cold Spring Harbor Laboratory Press; 1989. pp 916-919
    Google Scholar
  • 33 Zar JH. Biostatistical analysis. 2nd ed. Englewood Cliffs; Prentice-Hall: 1984. pp 313-314
    Google Scholar
  • 34 Iso H, Folsom AR, Winkelmann JC, Koike K, Harada S, Greenberg B, Sato S, Shimamoto T, Iida M, Komachi Y. Polymorphisms of the beta fibrinogen gene and plasma fibrinogen concentration in Caucasian and Japanese population samples. Thromb Haemost 1995; 73: 106-111
    Article in Thieme ConnectPubMedGoogle Scholar
  • 35 Thomas AE, Green FR, Kelleher CH, Wilkes HC, Brennan PJ, Meade TW, Humphries SE. Variation in the promoter region of the p-fibrinogen gene is associated with plasma fibrinogen levels in smokers and non-smokers. Thromb Haemost 1991; 65: 487-490
    Article in Thieme ConnectPubMedGoogle Scholar
  • 36 de MaatMPM, de KnijffP, Green FR, Thomas AE, Jespersen J, Kluft C. Gender-related association between β-fibrinogen genotype and plasma fibrinogen levels and linkage disequilibrium at the fibrinogen locus in Greenland Inuit. Arterioscler Thromb Vase Biol 1995; 15: 856-860
    CrossrefPubMedGoogle Scholar
  • 37 Humphries SE, Ye S, Talmud P, Bara L, Wilhelmsen L, Tiret L. European Atherosclerosis Research Study: Genotype at the fibrinogen locus (G-455-A β-gene) is associated with differences in plasma fibrinogen levels in young men and women from different regions in Europe. Evidence for gender-genotype-environment interaction. Arterioscler Thromb Vase Biol 1995; 15: 096-104
    CrossrefPubMedGoogle Scholar
  • 38 Behague I, Poirier O, Nicaud V, Evans A, Arveiler D, Luc G, Cambou J-P, Scarabin P-Y, Bara L, Green F, Gambien F. p fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction. The ECTIM study. Circulation 1996; 93: 440-449
    CrossrefPubMedGoogle Scholar
  • 39 Friedlander Y, Elkana Y, Sinnreich R, Kark JD. Genetic and environmental sources of fibrinogen variability in Israeli families: The Kibbutzim family Study. Am J Hum Genet 1995; 56: 1194-1206
    PubMedGoogle Scholar
  • 40 Rosenson RS, Tangney CC, Hafner JM. Intraindividual variability of fibrinogen levels and cardiovascular risk profile. Arterioscler Thromb 1994; 14: 1928-1932
    CrossrefPubMedGoogle Scholar
  • 41 Chambless LE, McMahon R, Wu K, Folsom A, Finch A, Shen Y-L. Shortterm intraindividual variability in hemostasis factors: the ARIC study. Ann Epidemiol 1992; 2: 723-733
    CrossrefPubMedGoogle Scholar
  • 42 Marckmann P, Sandström B, Jespersen J. The variability of and associations between measures of blood coagulation, fibrinolysis and blood lipids. Atherosclerosis 1992; 96: 235-244
    CrossrefPubMedGoogle Scholar
  • 43 Wilkes HC, Kelleher C, Meade TW. Smoking and plasma fibrinogen. Lancet 1988; 1: 307-308
    PubMedGoogle Scholar
  • 44 Yarnell JWG, Sweetnam PM, Rogers S, Elwood PC, Bainton D, Baker IA, Eastham R, O’Brian JR, Etherington MR. Some long term effects of smoking on the haemostatic system: A report from the Caerphilly and Speedwell Collaborative Surveys. J Clin Pathol 1987; 40: 909-913
    CrossrefPubMedGoogle Scholar
  • 45 Ernst E, Matrai A. Abstention from chronic cigarette smoking normalizes blood rheology. Atherosclerosis 1987; 64: 75-77
    CrossrefPubMedGoogle Scholar
  • 46 Yarnell JWG, Baker IA, Sweetnam PM, Bainton D, O’Brien JR, Whitehead PJ, Elwood PC. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies. Circulation 1991; 83: 836-844
    CrossrefPubMedGoogle Scholar
  • 47 Patel P, Mendall MA, Carrington D, Strachan DP, Leatham E, Molineaux N, Levy J, Blakeston C, Seymour CA, Camm AJ, Northfield TC. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. BMJ 1995; 311: 711-714
    CrossrefPubMedGoogle Scholar
  • 48 Sakata Y, Morimoto A, Long NC, Murakami N. Fever and acute-phase response induced in rabbits by intravenous and intracerebroventricular injection of interleukin-6. Cytokine 1991; 3: 199-203
    CrossrefPubMedGoogle Scholar
  • 49 Conti P, Bartle L, Barbacane RC, Reale M, Sipe JD. The down-regulation of IL-6-stimulated fibrinogen steady state mRNA and protein levels by human recombinant IL-1 is not PGE2-dependent: Effects of IL-1 receptor antagonist (IL-1RA). Mol Cell Biochem 1995; 142: 171-178
    CrossrefPubMedGoogle Scholar
  • 50 Rankinen T, Rauramaa R, Väisänen S, Penttilä I, Uusitupa M. Relation of habitual diet and cardiorespiratory fitness to blood coagulation and fibrinolytic factors. Thromb Haemost 1994; 71: 180-183
    Article in Thieme ConnectPubMedGoogle Scholar